| DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES |
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
The following table presents information about the fair value amounts of our cash flow derivative instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
Derivatives as of |
| |
|
|
March 31, 2026 |
|
December 31, 2025 |
| |
Balance Sheet Location |
|
Fair Value |
|
Fair Value |
Derivatives Designated as Hedging Instruments: |
|
|
|
|
Interest rate swap contracts |
Other assets |
|
$ |
792 |
|
|
$ |
721 |
|
|
|
|
|
|
|
Derivatives Not Designated as Hedging Instruments: |
|
|
|
|
|
|
|
|
|
|
Interest rate swap contracts |
Accrued expenses and other current liabilities |
|
$ |
37 |
|
|
$ |
— |
|
Interest rate swap contracts |
Other liabilities |
|
$ |
— |
|
|
$ |
197 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Make-whole provisions |
Other liabilities |
|
$ |
21,025 |
|
|
$ |
19,075 |
|
The following table presents information about the effects of our derivative instruments on our condensed consolidated statements of operations and condensed consolidated statements of comprehensive loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount of (Gain) Loss Recognized in Net Loss |
|
Location of (Gain) Loss Recognized in Net Loss |
|
Three Months Ended March 31, |
|
|
|
|
2026 |
|
2025 |
|
|
|
|
Derivatives Designated as Hedging Instruments: |
|
|
|
|
|
|
|
|
Interest rate swap contracts |
Other expenses, net |
|
$ |
(49) |
|
|
$ |
(107) |
|
|
|
|
|
Derivatives Not Designated as Hedging Instruments: |
|
|
|
|
|
|
|
|
Interest rate swap contracts |
Other expenses, net |
|
$ |
(160) |
|
|
$ |
927 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Make-whole provisions |
Other expenses, net |
|
$ |
1,950 |
|
|
$ |
408 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table presents the changes in Accumulated Other Comprehensive Income (“AOCI”), net of taxes, from our hedging instruments:
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2026 |
|
|
Derivatives Designated as Hedging Instruments: |
|
|
|
Accumulated gain in AOCL at the beginning of the period |
$ |
490 |
|
|
|
|
|
|
|
Unrealized gain recognized in AOCL |
102 |
|
|
|
Gain reclassified from AOCL to other expenses, net |
(49) |
|
|
|
Gain on derivatives |
53 |
|
|
|
Accumulated gain in AOCL at the end of the period |
$ |
543 |
|
|
|
The following tables present all of our active derivative instruments as of March 31, 2026:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Active Interest Rate Swaps |
|
|
|
Expiration Date |
|
Initial Notional
Amount ($) |
|
Status |
11-Year, 5.77% Fixed |
|
|
|
October 2029 |
|
$ |
9,200 |
|
|
Designated |
15-Year, 5.24% Fixed |
|
|
|
June 2033 |
|
$ |
10,000 |
|
|
Designated |
10-Year, 4.74% Fixed |
|
|
|
December 2027 |
|
$ |
14,100 |
|
|
Designated |
17.75-Year, 3.16% Fixed |
|
|
|
December 2040 |
|
$ |
14,084 |
|
|
Designated |
18-Year, 3.81% Fixed |
|
|
|
July 2041 |
|
$ |
32,021 |
|
|
Not Designated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other Derivatives |
|
Classification |
|
Effective Date |
|
Expiration Date |
|
Fair Value ($) |
Make-whole provisions |
|
Liability |
|
June/August 2018 |
|
December 2038 |
|
$ |
195 |
|
Make-whole provisions |
|
Liability |
|
August 2016 |
|
April 2031 |
|
$ |
13 |
|
Make-whole provisions |
|
Liability |
|
April 2017 |
|
February 2034 |
|
$ |
10 |
|
Make-whole provisions |
|
Liability |
|
November 2020 |
|
December 2027 |
|
$ |
1 |
|
Make-whole provisions |
|
Liability |
|
October 2011 |
|
May 2028 |
|
$ |
— |
|
Make-whole provisions |
|
Liability |
|
May 2021 |
|
April 2045 |
|
$ |
109 |
|
Make-whole provisions |
|
Liability |
|
March 2023 |
|
December 2047 |
|
$ |
1,327 |
|
Make-whole provisions |
|
Liability |
|
June 2022 |
|
March 2042 |
|
$ |
697 |
|
Make-whole provisions |
|
Liability |
|
July 2021 |
|
March 2046 |
|
$ |
1,854 |
|
Make-whole provisions |
|
Liability |
|
April 2024 |
|
June 2042 |
|
$ |
7,216 |
|
Make-whole provisions |
|
Liability |
|
April 2024 |
|
June 2042 |
|
$ |
1,012 |
|
Make-whole provisions |
|
Liability |
|
April 2025 |
|
September 2045 |
|
$ |
2,184 |
|
Make-whole provisions |
|
Liability |
|
May 2025 |
|
December 2037 |
|
$ |
270 |
|
Make-whole provisions |
|
Liability |
|
December 2025 |
|
September 2045 |
|
$ |
1,428 |
|
Make-whole provisions |
|
Liability |
|
December 2025 |
|
December 2046 |
|
$ |
1,230 |
|
Make-whole provisions |
|
Liability |
|
October 2025 |
|
December 2043 |
|
$ |
2,637 |
|
Make-whole provisions |
|
Liability |
|
October 2025 |
|
September 2040 |
|
$ |
842 |
|
|